The SAFD encourages the community to join the effort and help make a difference in the lives of those affected by muscular ...

Over half of the people who contributed to the report (53%) said they feel financially insecure. 17% of those reported feeling very insecure. And things have ...

Avidity Biosciences stock surges on expansion of pipeline targeting rare genetic cardiomyopathies and improvements in siRNA ...

Dyne Therapeutics, Inc. ( (DYN) ) has released its Q3 earnings. Here is a breakdown of the information Dyne Therapeutics, Inc. presented to its ...

Analyst Andrew Fein from H.C. Wainwright maintained a Buy rating on Dyne Therapeutics (DYN – Research Report) and keeping the price ...

Muscular Dystrophy, and more. "I fully support alternatives to using animals for research..." Westergaard told The Guardian ...

At Research Day, we shared preclinical data supporting 7's ... The dystrophin expression was quantified from two isoforms ...

Examples of forward-looking statements include, among others, statements relating to current and future clinical development of EryDex, including for the potential treatment of Ataxia-Telangiectasia ...

In-shoe sensors, AI and biomarkers will monitor muscular dystrophy and atrophy in children, adolescents and adults — with ...

Capricor presented preclinical data at the 2024 American Association of Extracellular Vesicles (AAEV) Annual Meeting ...